The Expert Panel Report* covers a comprehensive set of issues that reflects the complexity of asthma. It emphasizes throughout that appropriate therapy must be based on a clinician-client partnership in care as well as the role of the nurse in management and client and family education. Asthma is a dynamic disorder. Therefore, the report will be revised as scientific advances warrant. The current report reflects the NAEP's best current understanding of the disease.
References
1.
AasK. (1971). Controlled trial of hyposensitization to house dust.Acta Paediatrica Scandinavica, 60, 264.
2.
BanksD.E., and deShazoR.D. (1985). An overview of occupational asthma, principles of diagnosis and management.Immunology Allergy Practice, 7, 122–130.
3.
BeasleyR., RocheW.R., RobertsJ.A., & HolgateS.T. (1989). Cellular events in the bronchi in mild asthma and after bronchial provocation.American Review of Respiratory Disease, 139, 806–817.
4.
BeasleyR., CushelyR., and HolgateS.T. (1989). A self-management plan in the treatment of adult asthma.Thorax, 44, 200–204.
5.
BousheyH.A., HoltzmanM.J., ShellerJ.R., and NadelJ.A. (1980). Bronchial reactivity.American Review of Respiratory Disease, 121, 389–414.
BurdonJ.G.W., KillianK.J., HargreaveF.E., and CampbellE.J.M. (1982). The perception of breathlessness in asthma.American Review of Respiratory Disease, 126, 825–888.
CockroftD.W. (1987). Airway hyperresponsiveness: Therapeutic implications.Annals of Allergy, 59, 405–414.
10.
DjukanovicR., RocheW.R., WilsonJ.W., BeasleyC.R.W., TwentymanO.P., HowarthP.H., and HolgateS.T. (1990a). Mucosal inflammation in asthma.American Review of Respiratory Disease, 142, 863–871.
11.
DjukanovicR., WilsonJ., BrittenK., WilsonS., WallsA., RocheW., HowarthP., and HolgateS. (1990b). Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and health control subjects using immunohistochemistry.American Review of Respiratory Disease, 142, 863–871.
12.
EigenH., ReidJ.J., DahlR., Del BufaloC., FasanoL., and GunellaG. (1987). Evaluation of the addition of cromolyn sodium to bronchodilator maintenance therapy in the long-term management of asthma.Journal of Allergy and Clinical Immunology, 80, 612–621.
13.
HolgateS.T., BeasleyR., and TwentymanO.P. (1987). The pathogenesis and significance of bronchial hyperresponsiveness in airways disease.Clinical Specialties, 73, 561–572.
14.
HorstM., HejjaouiA., HorstV., MichelF.B., and BousquetJ. (1990). Double-blind, placebo-controlled rush immunotherapy with a standardized alternaria extract.Journal of Allergy and Clinical Immunology, 85, 460.
15.
Janson-BjerklieS., and ShnellS. (1988). Effect of peak flow information on patterns of self-care in adult asthma.Heart and Lung, 17, 543–549.
16.
LaitinenL.A., HeinoM., LaitinenA., KavaT., and HaahtelaT. (1985). Damage of the airway epithelium and bronchial reactivity in patients with asthma.American Review of Respiratory Disease, 131, 599–606.
17.
LiuM.C., BleekerE.R., LichtensteinL.M., Kagey-SobotkaA., NivY., McLemoreT.L., PermuttS., ProudD., and HubbardW.C. (1990). Evidence of elevated levels of histamine, prostaglandin D2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma.American Review of Respiratory Disease, 142, 126–132.
18.
McFaddenE.R., KiserR., and DeGrootW.J. (1973). Acute bronchial asthma: Relationships between clinical and physiological manifestations.New England Journal of Medicine, 288, 221.
19.
National Asthma Education Program (NAEP). (1991). The Expert Panel Report on the Guidelines for the Diagnosis and Management of Asthma.Bethesda, MD: author.
20.
National Center for Health Statistics (NCHS). (1980–1987). Vital statistics mortality data, multiple cause of death detail (machine-readable public-use data tape).Hyattsville, MD: U.S. Department of Health and Human Services, Public Health Service, CDC.
21.
NowakR.M., PenslerM.I., SarkarD.D., AndersonJ.A., KvaleP.A., and OrtizA.E. (1982). Comparison of peak expiratory flow and FEV1: Admission criteria for acute bronchial asthma.Annals of Emergency Medicine, 11, 64–69.
22.
OhmanJ.L.Jr., FindlayS.R., and LeitermanK.M. (1984). Immunotherapy in cat-induced asthma: Double-blind trial with evaluation of in vivo and in vitro responses.Journal of Allergy and Clinical Immunology, 74, 230.
23.
ReidM.J., MossR.B., and HsuY.P. (1986). Seasonal asthma in Northern California: Allergy causes and efficacy of immunotherapy.Journal of Allergy and Clinical Immunology, 78, 590.
24.
SearsM.R., TaylorD.R., PrintC.G., LakeD.C., LiQ., FlanneryE.M., YatesD.E., LucasM.K., and HerbisonG.P. (1990). Regular inhaled beta2-agonist treatment in bronchial asthma.Lancet, 336, 1391–1396.
25.
ShimC.S., and WilliamsM.H. (1980). Evaluation of severity of asthma: Patients versus physicians.American Journal of Medicine, 68, 1–13.
26.
ShimC.S., and WilliamsM.H. (1983). Relationship of wheezing to the severity of obstruction in asthma.Archives of Internal Medicine, 143, 890–892.
